BHVN Biohaven Ltd Forecast, Technical & Fundamental Analysis
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology... Show more
BHVN is expected to report earnings to fall 2.78% to -75 cents per share on November 17
Q3'26
Est.
$-0.76
Q2'26
Missed
by $0.03
Q1'26
Missed
by $0.04
Q4'25
Beat
by $0.28
Q3'25
Beat
by $0.24
The last earnings report on August 10 showed earnings per share of -77 cents, missing the estimate of -75 cents. With 2.33M shares outstanding, the current market capitalization sits at 2.56B.
A.I.dvisor indicates that over the last year, BHVN has been loosely correlated with BCYC. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if BHVN jumps, then BCYC could also see price increases.
Momentum Indicator for BHVN turns positive, indicating new upward trend
BHVN saw its Momentum Indicator move above the 0 level on August 26, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 99 similar instances where the indicator turned positive. In of the 99 cases, the stock moved higher in the following days. The odds of a move higher are at .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 53 cases where BHVN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for BHVN just turned positive on August 26, 2026. Looking at past instances where BHVN's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .
BHVN moved above its 50-day moving average on August 26, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where BHVN advanced for three days, in of 274 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The 10-day moving average for BHVN crossed bearishly below the 50-day moving average on August 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BHVN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
BHVN broke above its upper Bollinger Band on August 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BHVN entered a downward trend on August 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BHVN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BHVN's P/B Ratio (208.333) is slightly higher than the industry average of (20.323). P/E Ratio (0.000) is within average values for comparable stocks, (23.001). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.870). Dividend Yield (0.000) settles around the average of (0.017) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (442.867).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BHVN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
